Neuroscience
FDA OKs new drug for multiple sclerosis
(HealthDay)—A new pill for relapsing forms of multiple sclerosis (MS) has won approval from the U.S. Food and Drug Administration.
Mar 27, 2019
0
3
News tagged with drug evaluation
Medications
FDA approves first drug for rare form of rickets
(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).
Apr 23, 2018
0
4
Medical research
Kalydeco approval widened for more types of cystic fibrosis
(HealthDay)—The U.S. Food and Drug Administration says it has expanded approval for the cystic fibrosis drug Kalydeco (ivacaftor) to include 33 mutations of the disease, up from the previous 10 mutations.
May 18, 2017
0
0
Medications
FDA approves injectable psoriasis drug for tough cases
(HealthDay)—A new drug to treat tough cases of the skin condition psoriasis has won approval from the U.S. Food and Drug Administration.
Feb 16, 2017
0
1
Medications
FDA approves ocaliva for primary biliary cholangitis
(HealthDay)—Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response ...
Jun 1, 2016
0
4
Medications
FDA addresses concerns on approval of drugs to treat chronic hepatitis C
Treatment options for chronic hepatitis C, a serious and life-threatening infection, have improved substantially and several new regimens with shorter durations and improved efficacy and safety profiles are now available.
Jun 2, 2015
0
11
Medications
FDA approves new drugs for irritable bowel syndrome
(HealthDay)—Two new drugs for adults with irritable bowel syndrome with diarrhea (IBS-D) were approved by the U.S. Food and Drug Administration on Wednesday.
May 28, 2015
0
9
Medications
Biostatistician helps FDA approve first biosimilar drug
Bernard "Chip" Cole got the call in late December. The U.S. Food and Drug Administration summoned the University of Vermont biostatistician for another mission. Since 2013, Cole has sat on an important FDA panel that assesses ...
Apr 9, 2015
0
8
Medications
FDA: Akynzeo approved for chemo-related nausea / vomiting
(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...
Oct 11, 2014
0
0
Medications
FDA OKs new drug for hard-to-treat colitis and Crohn's
(HealthDay)—A new drug to treat adults with ulcerative colitis and Crohn's disease has been approved by the U.S. Food and Drug Administration.
May 21, 2014
0
0
